in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Cambrex Posts Loss On Pricing, Cost Issues
12:32 PM MST | February 27, 2009
Cambrex reported a net loss of $697,000 for the fourth quarter ended December 31, 2008. The company posted a net profit of $265,000 in the year-ago period. Sales in the 2008 quarter fell 6.6%, to $65.2 million. Operating profit decreased 48%, to $2.1 million. Gross margin decreased to 24.6% of sales, from 34.9% during the fourth quarter of 2007. Foreign currency unfavorably impacted gross margin by 0.2%, Cambrex says. The lower margins were driven by lower pricing mainly for a gastro-intestinal active pharmaceutical ingredient (API), increased bad debt reserves...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: